Ionis Pharmaceuticals Inc (IONS) Return on Assets ROA from the second quarter of 2026 to second quarter of 2025 and for the year 2026, Average High and Low, Fundamental Ratios from Jun 30 2026 to Mar 31 2025 - CSIMarket
CSIMarket Company Name, Ticker, Industry, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Ionis Pharmaceuticals Inc   (NASDAQ: IONS)


Ionis Pharmaceuticals Inc 's ROA from the second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Ionis Pharmaceuticals Inc 's ROA in the second quarter of 2026?
Ionis Pharmaceuticals Inc recorded a cumulative net loss of $-313 million during 12 months ending in the second quarter of 2026, resulting in a negative return on assets (ROA) of -9.67%.

However, within the Healthcare sector 288 other companies had a higher return on assets. While Return on assets, overall ranking has advanced in the Jun 30 2026 quarter, so far to 3220, from total ROA ranking in the first quarter of 2026 at 3809.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Jun 30 2026)
II. Quarter		 (Mar 31 2026)
I. Quarter		 (Dec 31 2025)
IV. Quarter		 (Jun 30 2025)
II. Quarter		 (Mar 31 2025)
I. Quarter
Y / Y Total Assets Change 6.45 % 14.86 % 14.37 % -48.41 % 1.77 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -313 -345 -357 -268 -458
Return On Assets (TTM) -9.67 % -10.81 % -11.59 % -9.03 % -12.48 %
IONS's Total Ranking # 3220 # 3809 # 3247 # 3253 # 3519
Total Assets (TTM) in million 2,995 3,450 3,524 2,985 2,813
Seq. Total Assets Change -13.2 % -2.1 % 18.05 % 6.12 % -6.35 %
Seq. Net Income Change - - - - -

IONS's 5 Years Annual ROA >> Back to IONS Management Effectiveness >> Compare IONS ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 100
Sector # 289
Overall # 3152

Return On Assets Statistics
High Average Low
14.26 %
-7.35 %
-25.5 %
(Sep 30 2019)   (Sep 30 2021)





Financial Statements
Ionis Pharmaceuticals Inc 's Assets $ 2,995 million IONS's Balance sheet
Ionis Pharmaceuticals Inc 's Income $ -115 million Quarterly IONS's Income Statement
IONS's Income by Division See IONS's Income by Division



Annual Return On Assets (Sep 30 2025)
FY 2025		 (Dec 31 2024)
FY 2024		 (Dec 31 2023)
FY 2023		 (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021
Y / Y Total Assets Change 0.98 % 0.45 % 18 % -2.96 % 9.26 %
Total Assets in million 3,033 3,004 2,990 2,534 2,611
Y / Y Net Income Change - - - - -
Net Income in million -129 -454 -366 -270 -29
Annual Return On Assets -4.24 % -15.11 % -12.25 % -10.64 % -1.1 %

IONS's 5 Years Annual ROA >> Back to IONS Management Effectiveness >> Compare IONS ROA to its Competitors



More Return On Assets Ratios
IONS's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
IONS's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for IONS's Competitors
Subscribers only: Roa for Ionis Pharmaceuticals Inc 's Suppliers
Subscribers only: Return On Assets for IONS's Customers

You may also want to know
IONS's Roi IONS's Inventory Turnover Ratio IONS's Growth Rates IONS's Dividend Comparisons
IONS's Profitability Ratios IONS's Asset Turnover Ratio IONS's Dividend Growth
IONS's Roe IONS's Valuation Ratios IONS's Financial Strength Ratios IONS's Dividend Payout Ratio



Companies with similar Return On Assets at Jun 30 2026, within Healthcare Sector ROA

Date modified: 2026-08-13T08:57:28+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.